Omega-3’s newest big fish reveals sector ambitions

Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through the ‘how’ and the ‘why’ of the move…and the ‘where’ it might lead.

“The opportunity to take a position in omega-3 – particularly a premium position – was really one that fit our growth ambitions quite well,” he said.

Rosenbaum discusses omega-3 formulation, regulation, science and more here and why it is looking to further invest in health and wellness.

The omega-3 sector has seen serious consolidation in recent years with acquisitions including Martek Biosciences (DSM, €830m), Ocean Nutrition Canada (DSM, €430m) and Pronova Biopharma (BASF, €690m).

Related Topics

SuppliersOmega-3s & nutritional oilsCardiovascular healthCognitive function

Related news

FMC to split into two publicly traded companies

FMC Corporation, owner of omega 3 fish oils leader EPAX, will split into two publically traded companies, the corporation announced recently.  The plan is to split the agricultural and nutrition segments off from the company’s industrial minerals divisions.